Mark J. Rosenblum

Companies

• Decoy Therapeutics Inc.Chief financial officer Sep 12, 2019 to now¹
• AdvaxisChief financial officer Jan 12, 2010 to Feb 4, 2014²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• DTDecoy Therapeutics Inc. DCOY11,363 shares³$13.4K at $1.18Aug 31, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 31, 2026Granted 9,682 shares of Decoy Therapeutics Inc.³
• Nov 20, 2025Bought 20,000 shares at $0.80 of Decoy Therapeutics Inc.⁴
• Feb 13, 2023Granted 6,432 shares of Decoy Therapeutics Inc.⁵
• Jan 3, 2023Granted 8,000 shares of Decoy Therapeutics Inc.⁶
• Nov 3, 2022Granted 1,488 shares at $1.73 of Decoy Therapeutics Inc.⁷
• Nov 3, 2022Granted 7,314 shares at $1.73 of Decoy Therapeutics Inc.⁸
• Nov 3, 2022Granted 7,314 shares at $1.73 of Decoy Therapeutics Inc.⁹
• May 31, 2022Bought 28,000 shares at $0.18 of Decoy Therapeutics Inc.¹⁰
• May 3, 2022Granted 10,000 shares at $0.19 of Decoy Therapeutics Inc.¹¹
• Mar 3, 2022Bought 76,246 shares at $0.39 of Decoy Therapeutics Inc.¹²
• Nov 3, 2021Granted 7,787 shares at $0.72 of Decoy Therapeutics Inc.¹³